Search results for "Platelet Factor 4"

showing 10 items of 18 documents

CX3CR1/CX3CL1 Axis Mediates Platelet–Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis

2018

AbstractMechanisms linking deep vein thrombosis (DVT) and subclinical atherosclerosis and risk of cardiovascular events are poorly understood. The aim of this study was to investigate the potential impact of CX3CR1/CX3CL1 axis in DVT-associated endothelial dysfunction. The study included 22 patients (age: 37.5 ± 8.2 years) with a history of idiopathic DVT and without known cardiovascular risk factors and 23 aged-matched control subjects (age: 34 ± 7.8 years). Flow cytometry was used to evaluate peripheral markers of platelet activation, leukocyte immunophenotypes and CX3CR1/CX3CL1 expression in both groups. A flow chamber assay was employed to measure leukocyte arrest under dynamic conditio…

AdultMale0301 basic medicinePathologymedicine.medical_specialtyAdolescentEndotheliumCX3C Chemokine Receptor 1InflammationComorbidity030204 cardiovascular system & hematologyMonocytesImmunophenotypingYoung Adult03 medical and health sciencesPlatelet Adhesiveness0302 clinical medicineRisk FactorsPlatelet adhesivenessHuman Umbilical Vein Endothelial CellsLeukocytesmedicineHumansPlateletLymphocytescardiovascular diseasesPlatelet activationEndothelial dysfunctionSistema cardiovascularInflammationVenous ThrombosisChemokine CX3CL1Tumor Necrosis Factor-alphabusiness.industryEndothelial CellsHematologyMiddle AgedPlatelet Activationmedicine.diseaseThrombosis030104 developmental biologymedicine.anatomical_structureMicroscopy FluorescenceCase-Control StudiesFemaleEndothelium Vascularmedicine.symptombusinessPlatelet factor 4Thrombosis and Haemostasis
researchProduct

The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood.

2005

Background There exists a current lack of information about the composition of the different types of plasma. No direct comparisons between apheresis plasma (AP) and recovered plasma (RP) derived from in-line-filtered whole blood (WB) have been published to date. Study design and methods Sixty AP units, 100 RP units from in-line-filtered WB held for 3 hours at 20 degrees C between donation and freezing, and an additional 100 RP units held for 15 hours at 20 degrees C before freezing were analyzed for coagulation factors and inhibitors, total protein, immunoglobulin G (IgG), and hemostasis and proteolysis activation markers. The influence of twice freezing and thawing on clotting factors V, …

AdultMaleImmunologyProtein SImmunoglobulin GCitric AcidAndrologyFactor IXLeukocyte CountPlasmaImmunology and AllergyHumansFactor XIWhole bloodClotting factorHemostasisFactor VIIIbiologyChemistryAnticoagulantsFactor VFibrinogenHematologyMiddle AgedApheresisCoagulationHemostasisImmunologybiology.proteinBlood Component RemovalFemaleLeukocyte ElastasePlatelet factor 4Transfusion
researchProduct

P-147PLASMA PLATELET FACTOR 4 AS PREDICTOR OF ANGIOGENIC ACTIVITY: DIAGNOSTIC AND PROGNOSTIC TOOL FOR EARLY STAGE NON-SMALL CELL LUNG CANCER

2013

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyAngiogenesisbusiness.industryCancermedicine.diseaseInternal medicinemedicineAdjuvant therapyAdenocarcinomaSurgeryStage (cooking)Cardiology and Cardiovascular MedicineLung cancerbusinessSurvival ratePlatelet factor 4Interactive CardioVascular and Thoracic Surgery
researchProduct

The impact of two whole blood inline filters on markers of coagulation, complement and cell activation

2005

Background and Objectives  There exists a current lack of information about the impact of different inline filters, used for the leucoreduction of whole blood (WB), on the levels of clotting factors and markers of coagulation, complement and cell activation in plasma. Only a few small comparisons of different types of WB inline filters have been published to date. Materials and Methods  This study compared two plasma types of 200 units each. Both study groups were derived from WB, inline-filtered and held for 2 h at 20° between donation and filtration. Then, 200 units (Group A) were filtered using a positively charged polyester filter (Baxter RZ2000) and the other 200 units (Group B) were f…

AdultMaleAdolescentFibrinogenNeutrophil ActivationThrombinmedicineHumansPlateletBlood CoagulationComplement ActivationAgedWhole bloodClotting factorChemistryHematologyGeneral MedicineMiddle AgedPlatelet ActivationMolecular biologyComplement systemImmunologyFemaleLeukocyte Reduction ProceduresCell activationBiomarkersFiltrationPlatelet factor 4medicine.drugVox Sanguinis
researchProduct

Beta-Thromboglobulin and Platelet Factor 4 in Juvenile Myocardial Infarction

2006

AdultMalemedicine.medical_specialtybusiness.industryAge FactorsMyocardial InfarctionHematologyGeneral Medicine030204 cardiovascular system & hematologyPlatelet Factor 4beta-Thromboglobulinmedicine.disease03 medical and health sciences0302 clinical medicineBeta-thromboglobulinInternal medicinemedicineCardiologyHumansJuvenileFemale030212 general & internal medicineMyocardial infarctionbusinessPlatelet factor 4Clinical and Applied Thrombosis/Hemostasis
researchProduct

A retrospective analysis of immunohistochemical determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian ca…

2018

Oncologymedicine.medical_specialtybusiness.industrymedicine.diseaseInterferonInternal medicineCohortRetrospective analysisMedicineImmunohistochemistrybusinessOvarian cancerPlatelet factor 4IRF4medicine.drugGeburtshilfe und Frauenheilkunde
researchProduct

Platelet activation markers in long-term follow-up of young subjects with acute myocardial infarction

2006

Beta-thromboglobulinPlatelet factor 4.Ischemic heart disease
researchProduct

The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.

2005

AbstractIn contrast with extensive documentation in patients treated with unfractionated heparin (UFH), the incidence of heparin-induced thrombocytopenia (HIT) in medical patients receiving low-molecular-weight heparin (LMWH) is less well defined. In a prospective cohort study, the platelet count was monitored in 1754 consecutive patients referred to 17 medical centers and treated with LMWH for prophylaxis or treatment of thromboembolic disorders. The diagnosis of HIT was accepted in case of a platelet drop of at least 50%, the absence of obvious explanations for thrombocytopenia, and the demonstration of heparin-dependent IgG antibodies. HIT developed in 14 patients (0.80%; 95% CI, 0.43%-1…

AdultMalemedicine.medical_specialtymedicine.drug_classImmunologyLow molecular weight heparinheparinPlatelet Factor 4BiochemistryCohort StudiesRisk FactorsHeparin-induced thrombocytopeniaInternal medicinemedicineHumansProspective StudiesProspective cohort studyAgedAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceCell BiologyHematologyHeparinHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombocytopeniaSurgeryClinical trialTreatment OutcomeFemaleComplicationbusinessCohort studymedicine.drugBlood
researchProduct

Cortisol, Platelet Serotonin Content, and Platelet Activity in Patients With Major Depression and Type 2 Diabetes

2015

OBJECTIVE Hypothalamic-pituitary-adrenal system dysfunction, serotonergic system alterations, and enhanced platelet activity may contribute to the increased cardiac risk in depression. This exploratory study examined associations between cortisol parameters, platelet serotonin (5-HT) content, and platelet activity markers in patients with newly diagnosed major depression (MD) and/or Type 2 diabetes (T2DM) compared with healthy controls. METHODS We compared cortisol awakening response (CAR), diurnal decrease in salivary cortisol concentrations (slope), platelet 5-HT, and platelet markers (CD40, CD40 ligand [CD40L], soluble CD40L, CD62P, β-thromboglobulin, and platelet factor-4) in 22 T2DM pa…

Blood PlateletsMaleSerotoninmedicine.medical_specialtyCortisol awakening responseHydrocortisoneCD40 LigandType 2 diabetesPlatelet Factor 4SerotonergicCoronary artery diseaseDiabetes mellitusInternal medicinemedicineHumansPlateletPlatelet activationCD40 AntigensSalivaApplied PsychologyDepressive Disorder Majorbusiness.industryCase-control studyMiddle Agedbeta-Thromboglobulinmedicine.diseaseP-SelectinPsychiatry and Mental healthEndocrinologyDiabetes Mellitus Type 2Case-Control StudiesFemalebusinessPsychosomatic Medicine
researchProduct

Introducing the new biomarker research approach into practice: Preliminary data from CXCL4 chemokine study in non-small cell lung cancer (NSCLC)

2012

Pulmonary and Respiratory MedicineOncologyCancer Researchmedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineBiomarker (medicine)non-small cell lung cancer (NSCLC)medicine.diseasebusinessPlatelet factor 4Lung Cancer
researchProduct